1 – 20 of 53
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines : a clinical implementation study
2024) In Breast Cancer Research and Treatment(
- Contribution to journal › Article
-
Mark
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers
(
- Contribution to journal › Article
- 2022
-
Mark
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants : Application of a points-based ACMG/AMP approach
(
- Contribution to journal › Article
- 2021
-
Mark
Genetic testing in women with early-onset breast cancer : a Traceback pilot study
(
- Contribution to journal › Article
- 2019
-
Mark
Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations
(
- Contribution to journal › Article
-
Mark
High patient satisfaction with a simplified BRCA1/2 testing procedure : long-term results of a prospective study
(
- Contribution to journal › Article
-
Mark
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
(
- Contribution to journal › Article
-
Mark
Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
(
- Contribution to journal › Article
- 2018
-
Mark
Germline mutations in BRCA1 and BRCA2 incidentally revealed in a biobank research study : experiences from re-contacting mutation carriers and relatives
(
- Contribution to journal › Article
-
Mark
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
(
- Contribution to journal › Article
-
Mark
Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study
(
- Contribution to journal › Article
- 2017
-
Mark
Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
(
- Contribution to journal › Article
- 2015
-
Mark
Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing
(
- Contribution to journal › Article
-
Mark
The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers
(
- Contribution to journal › Article
- 2014
-
Mark
Insights into breast cancer: New familial patterns and identification of a potential predictive marker
(
- Thesis › Doctoral thesis (compilation)
- 2012
-
Mark
Genetic factors in childhood cancer. Associations between tumors in childhood and adulthood, and prevalence of germline TP53 mutations
(
- Thesis › Doctoral thesis (compilation)
- 2011
-
Mark
High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer
(
- Contribution to journal › Article
-
Mark
A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicing
(
- Contribution to journal › Article
-
Mark
Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer
(
- Contribution to journal › Article